vs
Aquestive Therapeutics, Inc.（AQST）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
Aquestive Therapeutics, Inc.的季度营收约是Rocky Mountain Chocolate Factory, Inc.的1.7倍（$13.0M vs $7.5M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -244.8%，领先242.7%），Aquestive Therapeutics, Inc.同比增速更快（9.7% vs -4.4%），Rocky Mountain Chocolate Factory, Inc.自由现金流更多（$-1.3M vs $-8.6M），过去两年Aquestive Therapeutics, Inc.的营收复合增速更高（3.9% vs 1.9%）
Aquestive Therapeutics是一家特种制药企业，专注于中枢神经系统疾病创新疗法的开发与商业化。公司依托专有的药物递送技术打造便于患者使用的治疗方案，服务北美、欧洲市场的医疗机构与患者，核心管线覆盖神经学与精神病学领域的未满足医疗需求。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
AQST vs RMCF — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.0M | $7.5M |
| 净利润 | $-31.9M | $-155.0K |
| 毛利率 | 55.2% | 34.0% |
| 营业利润率 | -221.6% | 1.1% |
| 净利率 | -244.8% | -2.1% |
| 营收同比 | 9.7% | -4.4% |
| 净利润同比 | -86.8% | 81.7% |
| 每股收益（稀释后） | $-0.26 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $13.0M | $7.5M | ||
| Q3 25 | $12.8M | $6.8M | ||
| Q2 25 | $10.0M | $6.4M | ||
| Q1 25 | $8.7M | $8.9M | ||
| Q4 24 | $11.9M | $7.9M | ||
| Q3 24 | $13.5M | $6.4M | ||
| Q2 24 | $20.1M | $6.4M | ||
| Q1 24 | $12.1M | $7.3M |
| Q4 25 | $-31.9M | $-155.0K | ||
| Q3 25 | $-15.4M | $-662.0K | ||
| Q2 25 | $-13.5M | $-324.0K | ||
| Q1 25 | $-22.9M | $-2.9M | ||
| Q4 24 | $-17.1M | $-847.0K | ||
| Q3 24 | $-11.5M | $-722.0K | ||
| Q2 24 | $-2.7M | $-1.7M | ||
| Q1 24 | $-12.8M | $-1.6M |
| Q4 25 | 55.2% | 34.0% | ||
| Q3 25 | 64.8% | 23.6% | ||
| Q2 25 | 54.4% | 31.1% | ||
| Q1 25 | 58.1% | 10.8% | ||
| Q4 24 | 61.9% | 23.4% | ||
| Q3 24 | 67.2% | 31.8% | ||
| Q2 24 | 77.5% | 12.8% | ||
| Q1 24 | 63.6% | 24.3% |
| Q4 25 | -221.6% | 1.1% | ||
| Q3 25 | -89.6% | -7.0% | ||
| Q2 25 | -113.6% | -2.3% | ||
| Q1 25 | -222.1% | -30.3% | ||
| Q4 24 | -114.4% | -8.9% | ||
| Q3 24 | -61.2% | -14.3% | ||
| Q2 24 | 0.3% | -25.4% | ||
| Q1 24 | -74.3% | -21.7% |
| Q4 25 | -244.8% | -2.1% | ||
| Q3 25 | -120.6% | -9.7% | ||
| Q2 25 | -135.4% | -5.1% | ||
| Q1 25 | -263.0% | -32.5% | ||
| Q4 24 | -143.7% | -10.7% | ||
| Q3 24 | -85.0% | -11.3% | ||
| Q2 24 | -13.7% | -25.9% | ||
| Q1 24 | -106.4% | -21.9% |
| Q4 25 | $-0.26 | $-0.02 | ||
| Q3 25 | $-0.14 | $-0.09 | ||
| Q2 25 | $-0.14 | $-0.04 | ||
| Q1 25 | $-0.24 | $-0.38 | ||
| Q4 24 | $-0.18 | $-0.11 | ||
| Q3 24 | $-0.13 | $-0.11 | ||
| Q2 24 | $-0.03 | $-0.26 | ||
| Q1 24 | $-0.17 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $641.0K |
| 总债务越低越好 | $27.5M | — |
| 股东权益账面价值 | $-33.7M | $6.0M |
| 总资产 | $160.4M | $20.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $641.0K | ||
| Q3 25 | $129.1M | $2.0M | ||
| Q2 25 | $60.5M | $893.0K | ||
| Q1 25 | $68.7M | $720.0K | ||
| Q4 24 | $71.5M | $1.1M | ||
| Q3 24 | $77.9M | $973.0K | ||
| Q2 24 | $89.9M | $637.0K | ||
| Q1 24 | $95.2M | $2.1M |
| Q4 25 | $27.5M | — | ||
| Q3 25 | $45.0M | — | ||
| Q2 25 | $45.0M | — | ||
| Q1 25 | $45.0M | — | ||
| Q4 24 | $32.5M | — | ||
| Q3 24 | $45.0M | — | ||
| Q2 24 | $45.0M | — | ||
| Q1 24 | $45.0M | — |
| Q4 25 | $-33.7M | $6.0M | ||
| Q3 25 | $-4.1M | $6.1M | ||
| Q2 25 | $-72.6M | $6.7M | ||
| Q1 25 | $-60.9M | $7.0M | ||
| Q4 24 | $-60.2M | $9.8M | ||
| Q3 24 | $-45.4M | $10.5M | ||
| Q2 24 | $-35.5M | $9.0M | ||
| Q1 24 | $-36.3M | $10.6M |
| Q4 25 | $160.4M | $20.7M | ||
| Q3 25 | $163.6M | $22.3M | ||
| Q2 25 | $93.7M | $20.1M | ||
| Q1 25 | $102.2M | $21.2M | ||
| Q4 24 | $101.4M | $21.6M | ||
| Q3 24 | $110.0M | $21.1M | ||
| Q2 24 | $117.6M | $19.0M | ||
| Q1 24 | $129.5M | $20.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.5M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $-8.6M | $-1.3M |
| 自由现金流率自由现金流/营收 | -65.7% | -16.9% |
| 资本支出强度资本支出/营收 | 0.7% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-53.0M | — |
8季度趋势，按日历期对齐
| Q4 25 | $-8.5M | $-1.2M | ||
| Q3 25 | $-12.6M | $-488.0K | ||
| Q2 25 | $-7.9M | $350.0K | ||
| Q1 25 | $-23.4M | $1.2M | ||
| Q4 24 | $-6.5M | $-2.1M | ||
| Q3 24 | $-11.9M | $-3.5M | ||
| Q2 24 | $-7.0M | $-2.2M | ||
| Q1 24 | $-10.4M | $129.0K |
| Q4 25 | $-8.6M | $-1.3M | ||
| Q3 25 | $-12.9M | $-544.0K | ||
| Q2 25 | $-8.0M | $182.0K | ||
| Q1 25 | $-23.5M | — | ||
| Q4 24 | $-6.5M | — | ||
| Q3 24 | $-12.0M | $-4.6M | ||
| Q2 24 | $-7.0M | $-2.6M | ||
| Q1 24 | $-10.4M | $-352.3K |
| Q4 25 | -65.7% | -16.9% | ||
| Q3 25 | -100.6% | -8.0% | ||
| Q2 25 | -80.2% | 2.9% | ||
| Q1 25 | -269.9% | — | ||
| Q4 24 | -54.8% | — | ||
| Q3 24 | -88.3% | -72.6% | ||
| Q2 24 | -35.0% | -40.2% | ||
| Q1 24 | -86.4% | -4.9% |
| Q4 25 | 0.7% | 0.5% | ||
| Q3 25 | 1.8% | 0.8% | ||
| Q2 25 | 1.1% | 2.6% | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.6% | 17.5% | ||
| Q2 24 | 0.2% | 6.5% | ||
| Q1 24 | 0.2% | 6.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AQST
暂无分部数据
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
